These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39179349)

  • 1. Epigenetic regulation in ovarian cancer.
    Thi HV; Ngo AD; Chu DT
    Int Rev Cell Mol Biol; 2024; 387():77-98. PubMed ID: 39179349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of cancer-associated genes in ovarian cancer.
    Kwon MJ; Shin YK
    Int J Mol Sci; 2011 Jan; 12(2):983-1008. PubMed ID: 21541038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in ovarian cancer.
    Natanzon Y; Goode EL; Cunningham JM
    Semin Cancer Biol; 2018 Aug; 51():160-169. PubMed ID: 28782606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.
    Cicek MS; Koestler DC; Fridley BL; Kalli KR; Armasu SM; Larson MC; Wang C; Winham SJ; Vierkant RA; Rider DN; Block MS; Klotzle B; Konecny G; Winterhoff BJ; Hamidi H; Shridhar V; Fan JB; Visscher DW; Olson JE; Hartmann LC; Bibikova M; Chien J; Cunningham JM; Goode EL
    Hum Mol Genet; 2013 Aug; 22(15):3038-47. PubMed ID: 23571109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
    Sung HY; Yang SD; Park AK; Ju W; Ahn JH
    Yonsei Med J; 2017 Jan; 58(1):27-34. PubMed ID: 27873492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
    Singh AK; Chandra N; Bapat SA
    Clin Cancer Res; 2015 Nov; 21(22):5151-63. PubMed ID: 26130461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.
    Lyu T; Jia N; Wang J; Yan X; Yu Y; Lu Z; Bast RC; Hua K; Feng W
    Epigenetics; 2013 Dec; 8(12):1330-46. PubMed ID: 24135786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation Status and Expression of BRCA2 in Epithelial Ovarian Cancers in Indonesia.
    Pradjatmo H
    Asian Pac J Cancer Prev; 2015; 16(18):8599-604. PubMed ID: 26745123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in ovarian cancer: premise, properties, and perspectives.
    Yang Q; Yang Y; Zhou N; Tang K; Lau WB; Lau B; Wang W; Xu L; Yang Z; Huang S; Wang X; Yi T; Zhao X; Wei Y; Wang H; Zhao L; Zhou S
    Mol Cancer; 2018 Jul; 17(1):109. PubMed ID: 30064416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation profiles in ovarian cancer: implication in diagnosis and therapy (Review).
    Koukoura O; Spandidos DA; Daponte A; Sifakis S
    Mol Med Rep; 2014 Jul; 10(1):3-9. PubMed ID: 24821107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in ovarian cancer.
    Seeber LM; van Diest PJ
    Methods Mol Biol; 2012; 863():253-69. PubMed ID: 22359298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
    Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes.
    Matei D; Nephew KP
    Cancer Res; 2020 Sep; 80(18):3775-3785. PubMed ID: 32381656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomics and ovarian carcinoma.
    Maldonado L; Hoque MO
    Biomark Med; 2010 Aug; 4(4):543-70. PubMed ID: 20701443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.
    Sung HY; Park AK; Ju W; Ahn JH
    Yonsei Med J; 2014 Sep; 55(5):1206-13. PubMed ID: 25048476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.